Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$120M Buy
+3,970,660
New +$97.5M 3.2% 11
2025
Q3
Sell
-300,000
Closed -$7.48M 318
2025
Q2
$7.48M Buy
+300,000
New +$6.76M 0.2% 56
2025
Q1
Sell
-262,500
Closed -$7.34M 362
2024
Q4
$7.34M Buy
262,500
+70,000
+36% +$1.88M 0.18% 67
2024
Q3
$3.92M Sell
192,500
-287,500
-60% -$6.44M 0.1% 116
2024
Q2
$14.2M Sell
480,000
-15,000
-3% -$431K 0.4% 38
2024
Q1
$15.1M Buy
495,000
+270,000
+120% +$7.62M 0.43% 37
2023
Q4
$5.26M Sell
225,000
-100,000
-31% -$2.42M 0.17% 75
2023
Q3
$9.62M Buy
325,000
+25,000
+8% +$838K 0.17% 55
2023
Q2
$10.6M Buy
300,000
+8,420
+3% +$236K 0.22% 61
2023
Q1
$7.02M Buy
+291,580
New +$6.76M 0.17% 86
2021
Q3
Sell
-15,000
Closed -$712K 929
2021
Q2
$712K Buy
+15,000
New +$725K 0.01% 588

Other funds holding CFLT

UBS O'Connor's CFLT Position: Q4 2025 in Review

UBS O'Connor opened a new position in Confluent (CFLT) in Q4 2025: 3,970,660 shares worth $120M. The stake represents 3.2% of the portfolio and ranks #11 among its holdings. This is a return to the name: UBS O'Connor previously reported a position in CFLT as recently as Q2 2025.

UBS O'Connor first reported a position in CFLT in Q2 2021 and has held it in 11 quarters since. 426 funds tracked by Wall St. Rank hold CFLT as of Q4 2025.

  • UBS O'Connor held 3,970,660 shares of Confluent worth $120M as of Q4 2025.
  • Confluent was a new UBS O'Connor position in Q4 2025.
  • Confluent made up 3.2% of UBS O'Connor's portfolio in Q4 2025, its #11 holding.
  • UBS O'Connor first reported a position in Confluent in Q2 2021 and has held it in 11 quarters since.
  • 426 funds tracked by Wall St. Rank held Confluent as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.